Crossmark

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)

Crossref DOI link: https://doi.org/10.1136/bmjgast-2019-000353

Published Online: 2020-02-19

Published Print: 2020-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Olson, Janet E

Kirsch, Emily J

Edwards V, David K https://orcid.org/0000-0003-2708-9562
Kirt, Christine R

Kneedler, Bonny

Laffin, Jennifer J

Weaver, Amy L

St Sauver, Jennifer L

Yost, Kathleen J

Finney Rutten, Lila J
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04124406 at ClinicalTrials.gov

Documents that mention this clinical trial

Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage Study
https://doi.org/10.1136/bmjgast-2024-001376

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study) ^(Results)
https://doi.org/10.1136/bmjgast-2019-000353
Funding

Funding for this research was provided by:

Exact Sciences
License Information

License valid from 2020-02-19

Document is current

Any future updates will be listed below